Form 10-Q · Quarterly report

Danaher Corporation 10-Q, filed Oct 21, 2026

Filed
CIK
0000313616
Accession no.
0000313616-26-000199
AI-generated summary

Summary

Danaher Corporation filed its quarterly report on Form 10-Q for the three- and nine-month periods ended September 25, 2026, whose management discussion and analysis covers forward-looking statements, results of operations, liquidity and capital resources, and critical accounting estimates. The filing states that Danaher incurred debt to finance a portion of the purchase price for its acquisition of Masimo, and lists associated integration, indebtedness, and regulatory risks.

Key points

  • Danaher's 10-Q covers the three- and nine-month periods ended September 25, 2026.
  • Danaher incurred debt to finance part of the purchase price for its acquisition of Masimo.
  • The MD&A lists risks including tariffs and trade-related impacts, healthcare cost pressures, artificial intelligence development and deployment, and geopolitical conflict.
  • The report notes that 2025 U.S. administration policy changes and recent Supreme Court decisions have created regulatory and economic uncertainty.

Written by an AI model from the filing text. It can be incomplete or wrong; the filing on SEC.gov is the record.

From the filing

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) is designed to provide material information relevant to an assessment of Danaher Corporation’s (“Danaher,” the “Company,” “we,” “us” or “our”) financial condition and results of operations, including an evaluation of the amounts and certainty of cash flows from operations and from outside sources. …

An excerpt of the text as filed with the SEC, cut for length.

Readster writes AI-generated summaries of public filings for research purposes only. Summaries can be incomplete or wrong — check the original filing on SEC.gov before relying on it. Nothing here is investment, legal or medical advice.

Follow Danaher Corporation in Readster

Add Danaher Corporation to your watchlist and its SEC filings reach your brief alongside the news about it, every line cited to its source. Readster also follows topics, people, newsletters and podcasts.

No credit card. When the trial ends, you move to Readster Free unless you subscribe.